MAP3K13 was found to be commonly expressed, but its expression was at a low level in cancer tissues, and HCC patients with a low level of expression of MAP3K13 typically have bad prognosis, which suggested that MAP3K13 was a tumor suppressor gene. Here, MAP3K13 is linked to hepatocellular carcinoma.